Anti-flu drug Favipiravir (also known as T-705, Avigan, or favilavir) has been found effective in treating coronavirus (COVID-19).

https://www.theguardian.com/world/2020/mar/18/japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china

Have a look at this useful link.

https://www.elsevier.com/__data/assets/pdf_file/0007/988648/COVID-19-Drug-Therapy_Mar-2020.pdf

The article below may be useful.

Article Lopinavir; A Potent Drug against Coronavirus Infection: Insi...

Anti-flu drug Favipiravir (also known as T-705, Avigan, or favilavir) has been found effective in treating coronavirus (COVID-19).

https://www.theguardian.com/world/2020/mar/18/japanese-flu-drug-clearly-effective-in-treating-coronavirus-says-china

Thank you very much for your answers

Please also see the following link.

https://sph.nus.edu.sg/wp-content/uploads/2020/03/COVID-19-Science-Report-Therapeutics-13-Mar.pdf

Chloroquine (hydroxychloroquine/Plaquenil), a drug used to treat malaria and arthritis, was approved by the US Food and Drug Administration (FDA) to be tested as a treatment for COVID-19.

Favilavir, the first approved coronavirus drug in China

TJM2 by I-Mab Biopharma

I-Mab Biopharma is developed TJM2, a neutralising antibody, as a treatment for cytokine storm in patients suffering from a severe case of coronavirus infection. The drug targets the human granulocyte-macrophage colony-stimulating factor (GM-CSF), which is responsible for acute and chronic inflammation.

Coronavirus vaccine by Medicago

Medicago is developing drug candidates against COVID-19 after having produced Virus-Like Particles (VLP) of the coronavirus. The company has formed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2

AT-100 by Airway Therapeutics

Airway Therapeutics is exploring its novel human recombinant protein named AT-100 (rhSP-D) as a treatment for coronavirus. The company has announced a filing with the Respiratory Diseases Branch of the National Institutes of Health to evaluate the drug.

TZLS-501 by Tiziana Life Sciences

Tiziana Life Sciences is developing its monoclonal antibody named TZLS-501 for the treatment of COVID-19. TZLS-501 is a human anti-interleukin-6 receptor (IL-6R), which helps in preventing lung damage and elevated levels of IL-6.

OYA1 by OyaGen

OyaGen’s OYA1 has shown strong antiviral efficacy against coronavirus in laboratory essays. It was found to be more effective than chlorpromazine HCl in inhibiting SARS-CoV-2 from replicating in cell culture

BPI-002 by BeyondSpring 

BeyondSpring’s BPI-002 is a small molecule agent indicated for treating various infections including COVID-19. It has the ability to activate CD4+ helper T cells and CD8+ cytotoxic T cells and generating an immune response in the body.

Altimmune’s intranasal coronavirus vaccine

An intranasal Covid-19 vaccine is being developed by US-based clinical-stage biopharmaceutical company, Altimmune.

INO-4800 by Inovio Pharmaceuticals and Beijing Advaccine Biotechnology

Inovio Pharmaceuticals has collaborated with Beijing Advaccine Biotechnology Company to advance the development of the former’s vaccine, INO-4800, as a novel coronavirus vaccine. The company has started pre-clinical testing for clinical product manufacturing.

NP-120 (Ifenprodil) by Algernon Pharmaceuticals

Algernon Pharmaceuticals has announced that it is exploring its NP-120 (Ifenprodil) as a potential treatment COVID-19. Ifenprodil is an N-methyl-d-aspartate (NDMA) receptor glutamate receptor antagonist sold under the brand name Cerocal. It has demonstrated efficacy in improving survivability in mice infected with H5N1.

Source: https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/

Preprint Causes of the Spread of Coronavirus in Italy

What about Losartan?

Malaria drug has been used and proved to be effective and useful for sone cases.

Today the president of USA trump declares that Plaquenil and Azithromycin combination is extremely effective for coronavirus 2020.

Dear Dimitar Vasileff Georgieff, here is a review article published on drugs for Covid-19.

https://www.jstage.jst.go.jp/article/ddt/14/1/14_2020.01012/_pdf/-char/en

According to the following research article, Sofosbuvir, IDX-184, Ribavirin, and Remidisvir are potent drugs against the newly emerged HCoV disease.

Reference: Article Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

There are some existing antiviral and antibiotic drugs which is effective for corona virus:-

1. Oseltamivir Phosphate

2. Lopinavir

3. Ritonavir

4. Enticavir

5. Chloroquine

6. Favilavir

7. Erythromycin

8. Azithromycin

Remdesivir has been proved effective in various countries and also recommended by WHO

I think minocycline hydrochloride with N.acetylcysteine ,Aspirin and vitamin D, this combination will give the best outcomes, according to my theory MNad therory.

We need collaboration from institution to perform RCT.

Please also take a look at this useful link.

https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf

Dimitar Vasileff Georgieff

https://www.goodrx.com/blog/coronavirus-treatments-on-the-way/

https://www.audiology.org/audiology-today-mayjune-2020/online-feature-audiological-management-covid-19-survivors-treated

Minocycline +N.acetylcysteine + Aspirin and vitamin D , I am formulate a theory based on this combination (MNad theory).

I formulate it since March 2020 and publish it in April 2020.

single drug is not efficient for COVID.19 Syndrome.

Please take a look

https://www.audiology.org/audiology-today-mayjune-2020/online-feature-audiological-management-covid-19-survivors-treated

best regards

Remdesivir, Favipiravir, Tocilizumab, Dexamethasone have some proven benefits in the treatment of COVID-19.

https://www.trialsitenews.com/ivermectin-study-reveals-fantastic-results-100-of-60-patients-better-in-an-average-of-just-under-6-days/

Please also see the link below.

https://link.springer.com/content/pdf/10.1007/s40495-020-00216-7.pdf

Thank You for the link

"Ivermectin" is useful for the treatment of COVID-19.

Article Ivermectin: potential candidate for the treatment of Covid 19

Article Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Article A Wonder Drug in the Arsenal against COVID -19: Medication E...

Article White paper on Ivermectin as a potential therapy for COVID-19

Dexamethasone and favipiravir

UK regulators granted emergency-use authorization to a vaccine from drug firms Pfizer and BioNTech, just seven months after the start of clinical

I have personally taken Favipiravir and is very effective in low to moderate grade Corona virus infection. I had fever, violent coughing and bit of loose motion.

Please also have a look at this useful RG link.

Article Pharmacological treatments of COVID-19

Tocilizumab (Actemra) is an effective drug for treatment of severe COVID-19 patients.

Article Why tocilizumab could be an effective treatment for severe COVID-19?

Article Tocilizumab for the Treatment of Severe COVID‐19

Kindly check https://www.who.int/news-room/commentaries/detail/off-label-use-of-medicines-for-covid-19#:~:text=The%20use%20of%20licensed%20medicines,diseases%20should%20be%20avoided.

The antiviral drug remdesivir was FDA approved in October 2020 to treat certain hospitalized patients with COVID-19. And scientists are working hard to develop other effective treatments. Therapies that are under investigation include drugs that have been used to treat autoimmune diseases; additional antiviral drugs, and antibodies from people who have recovered from COVID-19. https://www.health.harvard.edu/diseases-and-conditions/treatments-for-covid-19

The FDA granted EUA to the first treatment, a monoclonal antibody called bamlanivimab made by Eli Lilly, based on an interim analysis of results from a well-designed but small clinical trial. The study looked at 465 non-hospitalized adults with mild to moderate COVID-19 symptoms who were at high risk of severe disease. A placebo was given to 156 of these patients. The remaining patients were given one of three different doses of bamlanivimab. Patients treated with the monoclonal antibody had a reduced risk (3% versus 10%) of being hospitalized or visiting the ER within 28 days after treatment, compared to patients given a placebo. This is a single-dose treatment that must be given intravenously and within 10 days of developing symptoms. https://www.health.harvard.edu/diseases-and-conditions/treatments-for-covid-19

Corticosteroids when patients are in Acute respiratory distress

Related questions about Covid-19:

https://www.researchgate.net/post/What_is_the_cause_for_reinfection_with_Covid-19_and_Covid-202

www.researchgate.net/post/Do_you_think_that_Covid-19_is_artificial_bioengineering_product

vitamins play important role in protection against corona virus complications certainly C and D vitamins.

Ивермектин, който изпробваха в нашата практика показа много добри резултати.

Up to date different medications used , but no single known protocol for corona virus for whole world.

Dear Dimitar Vasileff Georgieff,

The drug that has been used for several months in many countries in the treatment of people seriously ill with Covid-19 is blood plasma taken from people who have recovered from Covid-19 disease, with no symptoms or mild disease. However, currently (January 2021), the greatest hopes are placed on vaccines against Coronavirus administered to people.

Best regards,

Happy New Year 2021

Dariusz Prokopowicz